Fructose diphosphate and mean erythrocytic survival after extracorporeal circulation.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A Gasparetto.
Explore the source record for details and available documents.
In this study we have evaluated the efficacy and tolerance of ceftazidime used as the only antibiotic in the treatment of 19 critically ill patients, with serious infections caused by multiply resistant Gram-negative bacilli in an intensive care unit. The bacteria isolated showed a high susceptibility to ceftazidime and a moderate resistance to seven other antibiotics. Clinical improvement occurred in 42.1% of the patients treated. Tolerance, both local and general, to the drug was considered good. Ceftazidime appeared to be capable of replacing beta-lactam and aminoglycoside combinations in the treatment of serious infections caused by Gram-negative species in ICUs, but further experience is necessary.
Explore the source record for details and available documents.
After synthesizing modifications to hormonal and humoral factors following shock, a number of minor endocrine resonances detectable during and after ECC, or during cardiogenic shock of infarction genesis are considered. In small series of patients, renin activity, aldosterone, cortisol and 18-hydroxy-11-desoxycorticosteroid plasma levels were evaluated, the results providing interesting guidelines for extending hormonal researches into the above sector.
Explore the source record for details and available documents.
After some premises on the etiology of retinal detachment in children, the authors report their own surgical procedures. The indications, the advantages and disadvantages of the use of plastic or organic substances, with the effects of transitory or permanent plombages are discussed. Moreover, the anesthesiological problems concerning the preparation of young patients, the intraoperative phase and often numerous postoperative diagnostic controls are examined.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.